OBJECTIVE: Although spontaneous abortion (SAB) is common, recurrent SAB is far less common, with only 2-3% of women having 2 consecutive SABs and <1% having 3 or more consecutive SABs. Although the incidence of subsequent SAB has been well-defined in women with a history of recurrent pregnancy loss (RPL), prior studies evaluating perinatal outcomes in subsequent pregnancies have shown mixed results. In this study, we aimed to evaluate perinatal outcomes in our patient population in women with a history of RPL. STUDY DESIGN: Retrospective cohort study of singleton, non-anomalous gestations at 20 weeks who delivered at our academic institution. The exposed group was defined as women with a history of 2 consecutive SABs at <12 weeks. These women were compared to women with a history of 1 SAB at <12 weeks. The primary outcome was preterm birth at <37 weeks. Secondary outcomes included fetal growth restriction (FGR), gestational diabetes (GDM), hypertensive disorders of pregnancy, indication for preterm birth, gestational age (GA) at delivery, fetal demise, cesarean delivery, and a composite of neonatal complications (Apgar <5 at 5 minutes, perinatal death, and NICU admission). Multivariable logistic regression was performed to adjust for confounders, with the following variables considered in the model: maternal age, race, BMI, payor status, hypertension, and diabetes. RESULTS: Of 17,670 women included, 235 (1.3%) had a history of 2 consecutive SABs. Compared to women with a history of 1 SAB, women with RPL were not more likely to have a preterm birth (Table) . However, these women were more likely to have FGR (6% vs 2.4%,p¼<0.001, AOR 2.1, 95% CI: 1.1-3.8) and gestational DM (12.3% vs 6.6%, p¼<0.001, AOR 1.59, 95% CI: 1.04-2.43). All other maternal and neonatal outcomes were not statistically different. CONCLUSION: Women with a history of 2 consecutive SABs have an increased incidence of FGR and GDM in a subsequent pregnancy. Monitoring for these conditions in women with 2 consecutive SABs may be warranted. Georgetown University School of Medicine, Washington, DC OBJECTIVE: To identify the blood loss measurement technique that best predicts need for red blood cell (RBC) transfusion after cesarean delivery (CD) and to define the amount of blood, by technique, that predicts RBC transfusion. STUDY DESIGN: This was a retrospective review of a quality improvement initiative of all women with singleton pregnancies who underwent CD at >¼34 weeks' gestation between July 1, 2017 and June 30, 2018 at MedStar Washington Hospital Center. Women were eligible to have blood loss measured by visually estimated blood loss (EBL), gravimetric quantitative blood loss (QBL), Gauss Surgical's Triton ipad application (TBL) and a 24-hour postoperative complete blood count evaluation. Women with multifetal gestation, hypertensive disease and magnesium or anti-hypertensive treatment were excluded. The primary outcome was RBC transfusion. Receiveroperating characteristic curves with area under the curves (AUC) for RBC transfusion by blood loss measurement techniques were created by EBL, QBL and TBL. Blood loss volumes that best predict RBC transfusion were estimated according to blood loss measurement techniques. The secondary outcome included blood loss volumes that best predict RBC transfusion as estimated by measurement technique. We performed a secondary analysis after excluding women with preoperative hemoglobin <10 g/dL. RESULTS: Of the 444 women meeting inclusion criteria, 21 (4.7%) received RBC transfusion. Women who received RBC transfusion compared to women without RBC transfusion were more likely to have higher gravidity, intravenous fluid infusion, EBL, QBL, TBL, and lower preoperative hemoglobin levels (all P <.05). 
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